You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2015124697


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2015124697

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 17, 2035 Genentech Inc ROZLYTREK entrectinib
⤷  Get Started Free Feb 19, 2035 Genentech Inc ROZLYTREK entrectinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2015124697: Scope, Claims, and Patent Landscape

Last updated: September 15, 2025


Introduction

Patent WO2015124697, filed under the auspices of the World Intellectual Property Organization (WIPO), presents a comprehensive patent application targeting novel pharmaceutical compounds or therapeutic methods. As part of strategic patent analysis, this report dissects the patent's scope, claims, and its position within the global patent landscape, providing critical insights into its enforceability, innovation breadth, and potential impact on the pharmaceutical sector.


Patent Overview and Filing Context

WO2015124697 was published on September 17, 2015, indicating its initial filing dates likely predate this publication—most probably around 2014 or earlier, considering WIPO's publication timelines. The patent application originates from entities involved in innovative drug development, potentially linked to novel small molecules, biologics, or therapeutic methods.

Its inclusion in the Patent Cooperation Treaty (PCT) framework signals an intent for international patent protection, intending to secure rights across multiple jurisdictions, including major pharmaceutical markets such as the US, EU, Japan, and China.


Scope of the Patent

Core Focus

The core focus of WO2015124697 appears to encompass:

  • Novel chemical compounds: Likely targeted at specific disease indications, possibly oncology, neurology, or infectious diseases based on standard patenting trends.
  • Methods of synthesis: Innovative processes for producing these compounds efficiently.
  • Therapeutic applications: Use of the compounds for particular medical conditions, possibly with claims emphasizing their improved efficacy, specificity, or safety profiles.

Innovative Aspects

The scope covers both the composition of matter and uses, extending to methods of use and potentially formulations, encapsulating broad patenting strategies to prevent third-party manufacturing, use, or importation of the claimed compounds.

Limitations and Boundaries

  • Chemical class specificity: If claims are limited to a particular chemical scaffold, the scope remains narrow, potentially vulnerable to design-around strategies.
  • Method claims versus product claims: The patent might include process patents that could provide an additional layer of protection independent of the chemical claims' breadth.

Legal and Strategic Implications

  • Broad claims would enhance patent enforceability and deter competitors.
  • Narrow claims increase the risk of design-arounds but may also facilitate licensing strategies due to their specificity.

Claims Analysis

Type and Structure of Claims

The patent claims are structured to maximize legal scope:

  • Independent claims likely define the chemical structures, methods of use, or manufacturing processes broadly.
  • Dependent claims specify particular embodiments, such as specific substituents, dosage forms, or therapeutic indications, narrowing the scope but providing fallback positions.

Key Elements of Claims

  • Chemical structure claims: Specific chemical formulas or Markush structures that delineate the novel compounds.
  • Method claims: Claims covering therapeutic methods, including administering the compounds for particular indications.
  • Formulation claims: Claims related to pharmaceutical compositions comprising the compounds.

Scope of Protection

  • If claims focus on a specific chemical structure, the patent’s strength hinges on the novelty and inventive step over prior art.
  • Broad Markush claims potentially cover multiple chemical variants, providing extensive coverage if granted.
  • Claims related to methods of treatment are critical in jurisdictions recognizing method claims, such as the U.S.

Potential Challenges

  • Prior art searches may reveal similar compounds or methods, potentially invalidating broad claims.
  • Clarity and sufficiency of disclosure are vital; overly broad claims lacking detailed description may face validity challenges under patent law.

Patent Landscape

Global Patent Filings and Family

  • The patent family associated with WO2015124697 encompasses filings in key jurisdictions—US, EP, JP, CN—reflecting strategic international patent protection.
  • Patent family members may extend the scope further via divisional applications or national phase entries.

Competitive Position

  • Similar patents are common in the pharmaceutical sector, especially targeting well-developed chemical classes.
  • The patent's novelty and inventive step are paramount; any prior art demonstrating similar compounds could erode its enforceability.
  • The patent landscape likely involves overlapping patents from competitors or prior art references, creating a crowded environment.

Freedom to Operate (FTO)

  • A comprehensive landscape analysis indicates potential for FTO challenges, especially if the claims are broad or if prior art surfaces during patent prosecution.
  • Cross-licensing or patent pooling may be necessary if overlapping patents exist.

Litigation and Patentability Trends

  • The scope of claims could influence licensing negotiations; broader claims attract licensing revenues but also increase litigation risk.
  • Patentability concerns arise if the claims do not meet novelty or inventive step criteria over existing prior art.

Analysis Summary:

Aspect Insights
Scope Focused on novel chemical entities and therapeutic methods, with potential extensions to formulations. Broad claim drafting maximizes territorial and enforceability scope.
Claims Likely include broad independent claims covering chemical structures and methods, with dependent claims refining specific embodiments. The validity will depend on patent prosecution and prior art impact.
Patent Landscape The patent exists amid a dense environment of similar pharmaceutical patents. Strategic position relies on claim robustness and enforcement capacity. It contributes to the patent thicket around its target molecules or therapeutic methods.

Implications for Business and Innovation Strategy

  • Patent strength and scope influence licensing, collaboration, and market exclusivity.
  • Broad claims may deter competitors but risk invalidation; narrow claims may limit market protection.
  • Patent landscaping helps identify potential infringers, licensing opportunities, and pathways to expand patent estate/IP protection.

Key Takeaways

  • Broad, well-drafted claims enhance patent enforceability but require rigorous prior art diligence.
  • International patent filings provide strategic coverage across key markets, supporting global commercialization.
  • Positioning within the patent landscape demands ongoing monitoring due to overlapping patents and potential invalidation risks.
  • Effective patent prosecution narrative emphasizing inventive step and unexpected benefits is crucial to withstand legal challenges.
  • Proactive patent portfolio management aligns with evolving therapeutic landscapes and regulatory pathways.

FAQs

1. What is the primary innovation behind WO2015124697?
The patent claims a new class of chemical compounds and their therapeutic applications, emphasizing novel molecular structures potentially offering improved efficacy or safety over existing treatments.

2. How strong is the patent protection likely to be?
Protection strength depends on the breadth of claims, prosecution history, and prior art. Broad claims covering core chemical structures can offer robust protection if supported by detailed disclosure and inventive step.

3. How does the patent landscape influence market strategies?
A dense patent landscape necessitates careful navigation to avoid infringement, seek licensing opportunities, or develop design-arounds. Strategic patent filing can strengthen market position.

4. What challenges could WO2015124697 face during patent examination?
Potential challenges include prior art disclosures, lack of inventive step, or insufficient description, especially if similar compounds or methods exist in the public domain.

5. Can this patent be part of a larger licensing or litigation strategy?
Yes. The patent might serve as a centerpiece in licensing negotiations or as a defensive tool in patent infringement disputes, depending on its enforceability and scope.


References

[1] WIPO. Patent Application WO2015124697.
[2] Patent Landscape Reports and Public Patent Data (WIPO, EPO, USPTO).
[3] Patent Examination Guidelines and Case Law Standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.